
No Stock Yet
BioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
Conference Call scheduled on April 3, 2023, at 9 a.m. Eastern time bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)) today announced it will report financial results for the three months ended December 31, 2022, on
BioAffinity Technologies (NASDAQ:BIAF) Trading Down 2.8%
Shares of bioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Rating) fell 2.8% during mid-day trading on Tuesday . The company traded as low as $1.52 and last traded at $1.65. 11,254 shares were traded
BioAffinity Technologies, Subsidiary Oncoselect Therapeutics, Has Been Granted U.S. Patent Number 11,590,233 Titled "Porphyrin Compounds And Compositions Useful For Treating Cancer"
BioAffinity Technologies, Subsidiary Oncoselect Therapeutics, Has Been Granted U.S. Patent Number 11,590,233 Titled "Porphyrin Compounds And Compositions Useful For Treating Cancer"
BioAffinity Technologies (NASDAQ:BIAFW) Shares Down 3%
bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating)'s share price traded down 3% during mid-day trading on Friday . The company traded as low as $0.33 and last traded at $0.33. 101 shares trade
BioAffinity Technologies, Inc.'s Lock-Up Period To End on February 28th (NASDAQ:BIAF)
bioAffinity Technologies' (NASDAQ:BIAF – Get Rating) lock-up period will end on Tuesday, February 28th. bioAffinity Technologies had issued 1,282,600 shares in its IPO on September 1st. The total size
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersHumanigen (NASDAQ:HGEN) shares moved upwards by 31.9% to $0.24 during Tuesday's after-market session. This security traded at a volume of 7.2 million shares come close, making up 248.4% of its
BioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications
Company enlists Havas Health & You, Trinity Life Sciences to help build CyPath Lung brand SAN ANTONIO--(BUSINESS WIRE)--#CyPath--bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) today announced it
BioAffinity Technologies (NASDAQ:BIAFW) Shares Down 15.8%
bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) shares dropped 15.8% during mid-day trading on Wednesday . The company traded as low as $0.30 and last traded at $0.38. Approximately 8,092
Intel, KLA, Hasbro Among Premarket Losers' Pack
Sector Update: Health Care Stocks Still Sagging Near Close
03:56 PM EST, 01/24/2023 (MT Newswires) -- Health care stocks edged above their midday lows, with the NYSE Health Care Index sinking 0.8% Tuesday afternoon while the Health Care Select Sector SPDR Fun
Loading...
No Stock Yet